-transparent.png){kind=logo}
The authors describe the case of an epileptic patient in chronic therapy with carbamazepine, and with plasma concentration of the drug in therapeutical range, who suffers from persistent sinus tachycardia. At the present time the observations available in the literature on cardiac toxicity of carbamazepina concern the appearance of sinus tachycardia as consequence of overdose and of blocks of conduction in elderly with carbamazepine in therapeutical range.
Related Publications
M Checchini, and
M Magni, and
M Scaglione, and
A Vaccarella
July 1983,
Acta neurologica Scandinavica,
M Checchini, and
M Magni, and
M Scaglione, and
A Vaccarella
January 1996,
The American journal of psychiatry,
M Checchini, and
M Magni, and
M Scaglione, and
A Vaccarella
June 1987,
Archives of neurology,
M Checchini, and
M Magni, and
M Scaglione, and
A Vaccarella
September 1968,
Oral surgery, oral medicine, and oral pathology,
M Checchini, and
M Magni, and
M Scaglione, and
A Vaccarella
September 2009,
The neurologist,
M Checchini, and
M Magni, and
M Scaglione, and
A Vaccarella
January 2002,
Przeglad lekarski,
M Checchini, and
M Magni, and
M Scaglione, and
A Vaccarella
November 1985,
Archives of neurology,
M Checchini, and
M Magni, and
M Scaglione, and
A Vaccarella
January 1987,
Therapeutic drug monitoring,
M Checchini, and
M Magni, and
M Scaglione, and
A Vaccarella
May 2011,
Genome medicine,
M Checchini, and
M Magni, and
M Scaglione, and
A Vaccarella
July 1989,
Indian pediatrics,
